Stock Update: Eli Lilly and Company (NYSE:LLY) – Can 2014′s Riskiest Big Pharma Stock Launch a Comeback?

[at Motley Fool] – Eli Lilly missed the 2013 rally that propelled big pharma stocks like Pfizer and AstraZeneca. Can this company beat the patent cliff in the long term and turn things . . . → Read More: Stock Update: Eli Lilly and Company (NYSE:LLY) – Can 2014′s Riskiest Big Pharma Stock Launch a Comeback?

Eli Lilly and Company (NYSE:LLY) [at Motley Fool] – Eli Lilly missed the 2013 rally that propelled big pharma stocks like Pfizer and AstraZeneca. Can this company beat the patent cliff in the long term and turn things around for disappointed investors?
Read … [visit site to read more]

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.